Heart failure due to left ventricular systolic dysfunction: Treatment at discharge from hospital and at one year

International Journal of Cardiology

Volumn 103, Issue 3, 2005, Pages 286-292

  Houpe, D ^a   Peltier, M ^a   Cohen Solal, A ^b   Beguin M ^a   Levy F ^a   Slama, M ^a   Chapelain, K ^c   Tribouilloy, C ^a,d  

^a South Hospital   (France)

^b BEAUJON HOSPITAL   (France)

^c Department of Statistics   (France)

^d AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Ejection fraction; Heart failure; Medical treatment

Indexed keywords

AMIODARONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BENAZEPRIL; BEPRIDIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; CILAZAPRIL; DIGITALIS GLYCOSIDE; DIHYDROPYRIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; LISINOPRIL; LOOP DIURETIC AGENT; METOPROLOL; NITRATE; PERINDOPRIL; QUINAPRIL; RAMIPRIL; SPIRONOLACTONE; TRANDOLAPRIL; VERAPAMIL;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; DOSE RESPONSE; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SEX ROLE; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIURETICS; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE SURVEYS; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; SPIRONOLACTONE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 23644433808     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.08.060     Document Type: Article

References (25)

1. M. Senni, C. Tribouilloy, R.J. Rodeheffer, S.J. Jacobsen, J.M. Evans, and K.R. Bailey Congestive heart failure in the community. Trends in incidence and survival in a 10-year period Arch. Intern. Med. 159 1999 29 34
2. W.J. Remme, and K. Swedberg Guidelines for the diagnosis and treatment of chronic heart failure. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology Eur. Heart J. 22 2001 1527 1560
3. J.G. Cleland, A. Cohen-Solal, J.C. Aguilar, R. Dietz, J. Eastaugh, and F. Follath Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey Lancet 360 2002 1631 1639
4. A. Cohen-Solal, M. Desnos, F. Delahaye, J.P. Emeriau, and G. Hanania A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society Eur. Heart J. 21 2000 763 769
5. F. Zannad, S. Braincon, Y. Juilliere, P.M. Mertes, J.P. Villemot, and F. Alla Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study. Epidemiologie de l'Insuffisance Cardiaque Avancee en Lorraine J. Am. Coll. Cardiol. 33 1999 734 742
6. M. Komajda, F. Follath, K. Swedberg, J. Cleland, J.C. Aguilar, and A. Cohen-Solal The EuroHeart Failure Survey programme-A survey on the quality of care among patients with heart failure in Europe: Part 2. Treatment Eur. Heart J. 24 2003 464 475
7. M.M. McDermott, J. Feinglass, P. Lee, S. Mehta, B. Schmitt, and F. Lefevre Heart failure between 1986 and 1994: temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical center Am. Heart J. 134 1997 901 909
8. M. Ansari, M. Alexander, A. Tutar, D. Bello, and B.M. Massie Cardiology participation improves outcomes in patients with new-onset heart failure in the outpatient setting J. Am. Coll. Cardiol. 41 2003 62 68
9. M. Beguin, D. Houpe, M. Peltier, K. Chapelain, J.P. Lesbre, and C. Tribouilloy Epidemiology and aetiology of cardiac failure in the Somme Arch. Mal. Coeur. 97 2004 113 119
10. P.A. McKee, W.P. Castelli, P.M. McNamara, and W.B. Kannel The natural history of congestive heart failure: the Framingham study N. Engl. J. Med. 285 1971 1441 1446
11. M. Senni, R.J. Rodeheffer, C. Tribouilloy, J.M. Evans, S.J. Jacobsen, and K.R. Bailey Use of echocardiography in the management of congestive heart failure in the community J. Am. Coll. Cardiol. 33 1999 164 170
12. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF) Lancet 353 1999 2001 2007
13. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD investigators N. Engl. J. Med. 325 1991 293 302
14. H. Krum, A.M. Tonkin, R. Currie, R. Djundjek, and C.I. Johnston Chronic heart failure in Australian general practice. The Cardiac Aware Survey and Evaluation (CASE) Study Med. J. Aust. 174 2001 439 444
15. D.J. van Veldhuisen, A. Charlesworth, H.J. Crijns, K.I. Lie, and J.R. Hampton Differences in drug treatment of chronic heart failure between European countries Eur. Heart J. 20 1999 666 672
16. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, and A. Perez The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone evaluation study investigators N. Engl. J. Med. 341 1999 709 717
17. A. Heiat, C.P. Gross, and H.M. Krumholz Representation of the elderly, women, and minorities in heart failure clinical trials Arch. Intern. Med. 162 2002 1682 1688
18. M. Packer, M.R. Bristow, J.N. Cohn, W.S. Colucci, M.B. Fowler, and E.M. Gilbert The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol heart failure study group N. Engl. J. Med. 334 1996 1349 1355
19. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group N. Engl. J. Med. 316 1987 1429 1435
20. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitals Investigation Group N. Engl. J. Med. 336 1997 525 533
21. M. Echemann, F. Zannad, S. Briancon, Y. Juilliere, P.M. Mertes, and J.M. Virion Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction: the EPICAL study Am. Heart J. 139 2000 624 631
22. M.A. Pfeffer, J.J. McMurray, E.J. Velazquez, J.L. Rouleau, L. Kober, and A.P. Maggioni Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction N. Engl. J. Med. 349 2003 1893 1906
23. J.J. McMurray, J. Ostergren, K. Swedberg, C.B. Granger, P. Held, and E.L. Michelson Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Lancet 362 2003 767 771
24. R.S. Vasan, M.G. Larson, E.J. Benjamin, J.C. Evans, C.K. Reiss, and D. Levy Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction J. Am. Coll. Cardiol. 33 1999 1948 1955
25. M. Senni, C. Tribouilloy, R.J. Rodeheffer, S.J. Jacobsen, J.M. Evans, and K.R. Bailey Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, 1991 Circulation 98 1998 2282 2289